Lawrence S Cousens

This inventor holds 18 USPTO granted patents, primarily in Protein Engineering. Top assignees: Icos Corporation, Chiron Corporation. Active years: 1985-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lawrence S Cousens. Retrieved from https://idiyas.com/inventor/lawrence-s-cousens

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18

% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 11

Forward Citations = 707(Granted Patents)

Location History:

San Francisco, CA (US) (1985 - 1994)
Oakland, CA (US) (1996 - 2001)

Company Filing History:

Years Active: 1985-2001

Loading Chart...

Areas of Expertise:

Platelet-Activating Factor Acetylhydrolase

Recombinant Proteins

Therapeutic Uses

Antibodies

Detection Methods

Superoxide Dismutase

Hybrid DNA Synthesis

Insulin Secretion

Fused Genes

Adenovirus Promoter

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6203790 - Platelet-activating factor acetylhydrolase (2001-03-20),

2. 6146625 - Platelet-activating factor acetylhydrolase (2000-11-14),

3. 6099836 - Platelet-activating factor acetylhydrolase (PAF-AH) therapeutic uses (2000-08-08),

4. 6045794 - Platelet-activating factor acetylhydrolase (2000-04-04),

5. 5977308 - Platelet-activating factor acetylhydrolase (1999-11-02),

6. 5866362 - Enhanced purification and expression of insoluble recombinant proteins (1999-02-02),

7. 5847088 - Antibodies specific for platelet-activating factor acetylhydrolase (1998-12-08),

8. 5698403 - Methods of detecting platelet-activating factor acetylhydrolase using (1997-12-16),

9. 5656431 - Platelet-activating factor acetylhydrolase (1997-08-12),

10. 5641669 - Platelet-activating factor acetylhydrolase (1997-06-24),

11. 5605801 - Methods of detecting lesions in the platelet-activating factor (1997-02-25),

12. 5532152 - Platelet-activating factor acetylhydrolase (1996-07-02),

13. 5523215 - Enhanced purification and expression of insoluble recombinant proteins (1996-06-04),

14. 5342921 - Superoxide dismutase fusion polypeptides for expression of mammalian (1994-08-30),

15. 5015575 - Hybrid DNA synthesis of insulin (1991-05-14),

Title: The Innovations of Lawrence S Cousens

Introduction

Lawrence S Cousens is a notable inventor based in Oakland, CA (US). He has made significant contributions to the field of biotechnology, holding a total of 18 patents. His work primarily focuses on the development of therapeutic products that can regulate pathological inflammatory events.

Latest Patents

One of his latest patents is related to platelet-activating factor acetylhydrolase. This invention provides purified and isolated polynucleotide sequences encoding human plasma platelet-activating factor acetylhydrolase. Additionally, it includes materials and methods for the recombinant production of platelet-activating factor acetylhydrolase products, which are expected to be useful in regulating pathological inflammatory events.

Career Highlights

Throughout his career, Lawrence has worked with prominent companies in the biotechnology sector, including Icos Corporation and Chiron Corporation. His experience in these organizations has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Some of his notable coworkers include Christine D Eberhardt and Patrick W Gray. Their collaborative efforts have contributed to the advancement of research and development in their respective fields.

Conclusion

Lawrence S Cousens is a distinguished inventor whose work has had a profound impact on biotechnology. His patents and collaborations reflect his commitment to innovation and improving health outcomes.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]